新聞Parsterileproducts expands facilities to Rochester, Michigan, United States.Endo subsidiary Par Sterile Products will expand its Rochester, Michigan facility to begin the fill-finish manufacturing of both mRNA and adenovirus vaccines.
新聞Parsterileproducts partners with Novavax, Inc.Par Sterile Products has entered a nonexclusive agreement with Novavax to provide fill-finish manufacturing services at its Rochester, MI, plant for Novavax's COVID-19 vaccine candidate.
新聞Parsterileproducts filed suit against QuVa Pharma, Inc. on Aug 1st '17.In August 2017, Par filed a complaint against QuVa and several individual defendants in the U.S.
